Pluripotent stem cell models of human heart disease
- PMID: 24186488
- PMCID: PMC3808770
- DOI: 10.1101/cshperspect.a014027
Pluripotent stem cell models of human heart disease
Abstract
Understanding the molecular basis of many cardiac diseases has been hampered by the lack of appropriate in vitro cell culture models that accurately reflect the human disease phenotypes. In the past few years, remarkable advances in stem cell biology have made possible this long-standing ambition-the generation of human and even patient-specific cellular models of diseases. Combined with other novel technologies in the fields of human genetics, tissue engineering, and gene-targeted manipulation, disease modeling with pluripotent stem cells has the promise to influence modern cardiovascular medicine on several fronts: molecular understanding of pathological mechanisms, early diagnosis, drug development, and effective treatment.
Figures
Similar articles
-
Stem Cells: The Game Changers of Human Cardiac Disease Modelling and Regenerative Medicine.Int J Mol Sci. 2019 Nov 16;20(22):5760. doi: 10.3390/ijms20225760. Int J Mol Sci. 2019. PMID: 31744081 Free PMC article. Review.
-
Cardiac differentiation of pluripotent stem cells and implications for modeling the heart in health and disease.Sci Transl Med. 2018 Apr 4;10(435):eaah5457. doi: 10.1126/scitranslmed.aah5457. Sci Transl Med. 2018. PMID: 29618562 Review.
-
Pluripotent Stem Cell-Based Platforms in Cardiac Disease Modeling and Drug Testing.Clin Pharmacol Ther. 2017 Aug;102(2):203-208. doi: 10.1002/cpt.722. Clin Pharmacol Ther. 2017. PMID: 28718902 Review.
-
Generation of human cardiomyocytes for cardiac regenerative therapies: differentiation and direct reprogramming.Curr Pharm Des. 2014;20(12):2012-22. doi: 10.2174/13816128113199990448. Curr Pharm Des. 2014. PMID: 23844731 Review.
-
Cardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models.Biochem J. 2011 Feb 15;434(1):25-35. doi: 10.1042/BJ20101707. Biochem J. 2011. PMID: 21269276 Review.
Cited by
-
Cellular models in autoinflammatory disease research.Clin Transl Immunology. 2024 Jan 11;13(1):e1481. doi: 10.1002/cti2.1481. eCollection 2024. Clin Transl Immunology. 2024. PMID: 38213819 Free PMC article. Review.
-
Human pluripotent-stem-cell-derived organoids for drug discovery and evaluation.Cell Stem Cell. 2023 May 4;30(5):571-591. doi: 10.1016/j.stem.2023.04.011. Cell Stem Cell. 2023. PMID: 37146581 Free PMC article. Review.
-
Human in vitro neurocardiac coculture (ivNCC) assay development for evaluating cardiac contractility modulation.Physiol Rep. 2022 Nov;10(21):e15498. doi: 10.14814/phy2.15498. Physiol Rep. 2022. PMID: 36325586 Free PMC article.
-
Precision medicine journey through omics approach.J Diabetes Metab Disord. 2021 Nov 24;21(1):881-888. doi: 10.1007/s40200-021-00913-0. eCollection 2022 Jun. J Diabetes Metab Disord. 2021. PMID: 35673436 Free PMC article. Review.
-
Chronic Cardiotoxicity Assays Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs).Int J Mol Sci. 2022 Mar 16;23(6):3199. doi: 10.3390/ijms23063199. Int J Mol Sci. 2022. PMID: 35328619 Free PMC article. Review.
References
-
- Anderson D, Self T, Mellor IR, Goh G, Hill SJ, Denning C 2007. Transgenic enrichment of cardiomyocytes from human embryonic stem cells. Mol Therapy 15: 2027–2036 - PubMed
-
- Blin G, Nury D, Stefanovic S, Neri T, Guillevic O, Brinon B, Bellamy V, Rucker-Martin C, Barbry P, Bel A, et al. 2010. A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J Clin Invest 120: 1125–1139 - PMC - PubMed
-
- Bruneau BG 2008. The developmental genetics of congenital heart disease. Nature 451: 943–948 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous